ACTRN12623000592640招募中1 期
Comparing broccoli sprout supplement formulations for circulating sulforaphane concentration in non-pregnant and pregnant women
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Female
入选标准
- •Group 1: Healthy, non-pregnant women
- •Not pregnant.
- •Deemed capable of understanding the information provided and able to give written informed consent (with interpreter use as required).
- •Body mass index (BMI) between 18 – 35kg/m2.
- •Greater than or equal to 18 years of age
- •Group 2: Healthy, pregnant women
- •Singleton pregnancy.
- •Gestation between 28+0 and 36+0 weeks pregnant.
- •Normal mid-trimester morphology scan, with no detectable significant anomalies.
- •Deemed capable of understanding the information provided and able to give written informed consent (with interpreter use as required).
- •Booking body mass index (BMI) between 18 – 35kg/m2.
- •Greater than or equal to 18 years of age
- •Group 3: Pregnant women with a hypertensive disorder of pregnancy
- •Singleton pregnancy.
- •Gestation between 28+0 and 36+0 weeks pregnant.
- •Diagnosis of hypertension in pregnancy or preeclampsia
- •Deemed capable of understanding the information provided and able to give written informed consent (with interpreter use as required).
- •Booking body mass index (BMI) between 18 – 35kg/m2.
- •Greater than or equal to 18 years of age
排除标准
- •Group 1: Healthy, non-pregnant women
- •Participant exclusion criteria:
- •< 18 years of age.
- •Body mass index (BMI) < 18 or > 35kg/m2.
- •Confirmed or suspected pregnancy.
- •Current use of broccoli sprout extract supplement.
- •Contraindications to use (e.g., intolerance of broccoli).
- •Significant uncertainty in ensuring gestational age is within limits.
- •Unwillingness or inability to follow the procedures outlined in the PI and CF.
- •Mentally, cognitively or legally incapacitated or ineligible to provide informed consent.
- •Co-recruitment/participation in another clinical trial where there is a pharmaceutical or herbal or nutritional intervention (such trial interventions would also include: multi-vitamins, minerals, complementary and alternative medicines).
- •Group 2: Healthy, pregnant women
- •Participant exclusion criteria:
- •major complications of pregnancy including but not limited to:
- •oFetal growth restriction estimated fetal weight <10th centile or AC (abdominal circumference) <5th
- •oPreeclampsia/HELLP syndrome (haemolysis elevated liver enzymes low platelet syndrome)
- •oGestational diabetes on insulin on >20units insulin/day
- •oPPROM (preterm pre-labour rupture of membranes) within 7 days ago
- •oChorioamnionitis
- •oStillbirth or intrauterine fetal death
- •oSuspected or confirmed congenital infection of pregnancy (i.e. CMV, syphilis, rubella)
- •oUnstable major placenta praevia or vasa praevia
- •oHypertensive disorder of pregnancy on >1 regular anti-hypertensive treatment
- •oAbnormal umbilical artery doppler i.e. elevated umbilical artery doppler pulsatility index (UA PI >95th), absent end-diastolic flow or reversal of end-diastolic flow, or a reduced middle cerebral artery pulsatility index (MCA PI <5th) or abnormal ductus venosus (DV)
- •Renal or hepatic dysfunction.
- •Current use of broccoli sprout extract supplement.
- •Contraindications to use (e.g., intolerance of broccoli).
- •Significant uncertainty in ensuring gestational age is within limits.
- •Unwillingness or inability to follow the procedures outlined in the PI and CF.
- •Mentally, cognitively or legally incapacitated or ineligible to provide informed consent.
- •Co-recruitment/participation in another clinical trial where there is a pharmaceutical or herbal or nutritional intervention (such trial interventions would also include: multi-vitamins, minerals, complementary and alternative medicines).
- •Group 3: Pregnant women with a hypertensive disorder of pregnancy
- •Participant exclusion criteria:
- •major complications of pregnancy including but not limited to:
- •oFetal growth restriction estimated fetal weight <10th centile or AC (abdominal circumference) <5th
- •oGestational diabetes on insulin on >20units insulin/day
- •oPPROM (preterm pre-labour rupture of membranes) within 7 days ago
- •oChorioamnionitis
- •oStillbirth or intrauterine fetal death
- •oSuspected or confirmed congenital infection of pregnancy (i.e. CMV, syphilis, rubella)
- •oUnstable major placenta praevia or vasa praevia
- •oAbnormal umbilical artery doppler i.e. elevated umbilical artery doppler pulsatility index (UA PI >95th), absent end-diastolic flow or reversal of end-diastolic flow, or a reduced middle cerebral artery pulsatility index (MCA PI <5th) or abnormal ductus venosus (DV)
- •Current use of broccoli sprout extract supplement.
- •Contraindications to use (e.g., intolerance of broccoli).
- •Significant uncertainty in ensuring gestational ag
研究者
相似试验
已完成
不适用
Evaluation of the effect of broccoli-supplements intake on blood antioxidant levels and search for new biomarkersHealthy adultsJPRN-jRCTs021210018Itoh Ken30
尚未招募
Unknown
Assessing the effects of a broccoli sprout extract on flow-mediated dilatiohypertension in pregnancyReproductive Health and Childbirth - Fetal medicine and complications of pregnancyCardiovascular - HypertensionAlternative and Complementary Medicine - Other alternative and complementary medicineACTRN12624000812594Monash Health30
已完成
不适用
Effects of broccoli sprouts powder supplementation on clinical and biochemical parameters in metabolic syndrome patients with positive Helicobacter Pylori testmetabolic syndrom.Nutritional and metabolic disorders in diseases classified elsewhereIRCT201111081640N6Research Institute for Endocrine Sciences, Shahid Beheshti Medical Sciences University90
已完成
不适用
Broccoli Supplement Dose ResponseHealthy VolunteersNCT03399656Johns Hopkins Bloomberg School of Public Health170
已完成
不适用
Study on health benefits of the broccoli Super SproutHealthy volunteerJPRN-UMIN000027106Tokai University24